Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background:

Fetal growth restriction (FGR) is the single greatest cause of stillbirth. An effective first-trimester screening test would identify pregnancies at 'high-risk' thereby targeting NHS resources towards those at-risk enabling delivery before stillbirth occurs. FGR can be predicted at 11-13 weeks' using placental volume and vascularity, but no method is currently available to estimate these which can be used for population-screening.

 

Aims:

To use an observational cohort study to examine the utility of the OxNNet Toolkit for the prediction of FGR in an unselected population presenting for routine first-trimester scanning.

 

Objectives:

  • To assess the ability of the OxNNet Toolkit placental metrics to predict FGR and other adverse pregnancy outcomes in an unselected cohort presenting for first-trimester screening by NHS sonographers.

 

  • To facilitate full healthcare economic analysis based on the predictive ability of the screening result.

 

Work Packages:

 

WP1: Train NHS sonographers to perform the 3D ultrasound scan and develop training-protocols and manuals.

WP2: Undertake the OxPLUS study to examine prediction of FGR using the OxNNet Toolkit placental metrics.

 

WP3: Perform a health economic evaluation that assesses the cost-effectiveness of the routine employment of the test

 

Anticipated Impact

This should produce two major value propositions: better pregnancy outcomes and economic benefits from preventing unnecessary imaging.